Tech Company Financing Transactions
Inception IBD Funding Round
Inception IBD, based in San Diego, raised $14.1 million from Versant Ventures, Fonds de solidarite FTQ and private investors.
Transaction Overview
Company Name
Announced On
12/14/2015
Transaction Type
Venture Equity
Amount
$14,100,000
Round
Series A
Investors
Versant Ventures (Lead Investor)
Proceeds Purpose
The funds will be used to advance a portfolio of therapeutics targeting the underlying pathogenesis of inflammatory bowel disease (IBD).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Inception IBD is focused on translating academic discoveries in the field of IBD into first-in-class small molecule drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Eric Ogier-Denis
Browse more venture capital transactions:
Prev: 12/14/2015: RiverMend Health venture capital transaction
Next: 12/14/2015: Solarflare Communications venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs